Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,513.28
(
-0.08%
)
US TECH 100
29,129.00
(
-0.28%
)
Dow Jones
50,633.31
(
0.34%
)
Brent Oil
93.10
(
-4.01%
)
Bitcoin
74,953.87
(
-1.18%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

CuresForHumanity

Send PM Follow Ignore
Followers 13
Posts 608
Boards Moderated 0
Alias Born 06/05/2015

CuresForHumanity

Re: Robert C Jonson post# 225253

Saturday, 07/04/2015 5:24:02 PM

Saturday, July 04, 2015 5:24:02 PM

Post# of 347009
Robert,
Phase 2, all patients had previously treated Stage IIIb or IV non-squamous NSCLC. Phase 3 study states the same,
"SUNRISE: A Phase III, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Previously Treated Stage IIIb/IV Non-Squamous Non Small-Cell Lung Cancer"

Am I missing something?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote